UNCLAIMED
Cepheid
Overview
Cepheid is a U.S.-based company established in 1996, specializing in the manufacturing of test and measurement equipment, particularly in the field of molecular diagnostics. The company focuses on advancing point-of-care testing (POCT) solutions, with an emphasis on molecular tests that utilize nucleic acid amplification techniques, such as polymerase chain reaction (PCR). Their published documents highlight best practices for molecular POCT, emphasizing the importance of training, quality control, and proper sample handling to ensure reliable testing results. Cepheid's white papers and technical reports discuss the decentralization of diagnostics, aiming to bring patient-centered testing closer to communities, and address the implications of molecular testing in public health contexts. Additionally, research reports from Cepheid explore the intersection of healthcare quality and efficiency, aligning with broader healthcare objectives. The company's commitment to improving diagnostic capabilities is evident in their focus on developing accessible and accurate testing solutions to enhance clinical care and patient outcomes.